Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

After Running Lilly From China, CEO Says Local Commitment, Innovation Remain Priorities

Apr 05 2011

• By PharmAsia News

Related Content

Boehringer Ingelheim Opens R&D Center In Shanghai; Sees Sales Growth From Products On NDRL Reimbursement List

Sep 06 2010

Abbott, Eli Lilly, Novartis: Emerging Markets Earnings Round Up (Part 1)

Feb 08 2011

Emerging Markets Round Up From JP Morgan Healthcare Conference (Part 1 of 2)

Jan 17 2011

Big Pharma Takes Another Haircut As China Slashes Drug Prices In Two Largest Therapy Fields

Mar 08 2011

Lilly CEO, In Shanghai, Predicts Better Patent Protection Will Unleash Scientific Innovation Across China

Apr 02 2010

China's NDRC Releases First Set Of Price Cuts; MNCs See Deepest Cuts As Expected

Dec 01 2010

Lilly Shifts Gears In China With New Shanghai-based R&D Center

Nov 03 2010

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window